If I only Have Osteopenia, Not Osteoporosis, Am I Okay? No, You're Still at Risk! | Felice Gersh, MD

Felice Gersh, MD
Felice Gersh, MDApr 20, 2026

Why It Matters

Because osteopenia accounts for the majority of hip fractures, an effective, microbiome‑based supplement could dramatically lower fracture incidence and healthcare costs for a large at‑risk population.

Key Takeaways

  • Osteopenia accounts for 54% of women's hip fractures
  • Bone Dia is a probiotic medical food targeting gut‑bone axis
  • Trial enrolled 286 peri‑menopausal women, treated for one year
  • Bone Dia cut hip bone loss by roughly 85% in high‑risk group
  • Probiotic blend uses fruit‑vegetable strains producing anti‑inflammatory compounds

Summary

The video explains that osteopenia, often perceived as a milder condition than osteoporosis, still carries substantial fracture risk, especially for women.

Data reveal that 54% of hip fractures in women occur in those with osteopenia, and a recent randomized, placebo‑controlled trial of 286 women within six years of menopause showed Bone Dia reduced hip bone loss by about 85% in the highest‑risk participants.

Dr. Gersh describes Bone Dia as a “symbiotic medical food” containing four fruit‑and‑vegetable‑derived probiotic strains that act like “the Avengers,” producing anti‑inflammatory compounds via the gut‑bone axis.

If validated, this probiotic approach could shift prevention strategies toward early nutritional interventions, offering a non‑pharmaceutical option for millions of women with osteopenia.

Original Description

When we talk about fracture risk, most people think of osteoporosis. But the numbers tell a different story. Because osteopenia is so common, more than half of hip fractures in women occur in those with osteopenia, not osteoporosis. The risk isn’t only at the extreme. It lives in the middle.
This is where the gut–bone axis becomes important. The microbiome influences inflammation, immune signaling, and ultimately bone turnover. Targeting that pathway offers another layer of protection.
One approach is Bondia—a symbiotic formula designed to support the microbiome with specific probiotics that work together to generate anti-inflammatory compounds. In clinical research, women near menopause taking Bondia showed dramatically reduced hip bone loss compared with placebo.
Bondia is a probiotic specially formulated to slow bone loss
Discount code:
Use FELICEGERSH (case sensitive) for 20% off your first order.
Learn more, watch my full talk,
The Gut–Bone Connection that can lower osteoporosis risk
#osteopenia #osteoporosisprevention #bonehealth #probiotics #clinicalresearch

Comments

Want to join the conversation?

Loading comments...